🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07410754
Starting soon Not applicable

Effect of Combined Skin-to-Skin Contact and Kangaroo Care on Breastfeeding and Bonding in Cesarean-Born Newborns

NCT07410754 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03
Last updated
2026-02-13

Condition(s) studied

BreastfeedingSkin to Skin ContactCesarean BirthKangaroo Care

Investigational drug(s) / intervention(s)

Intervention

Intervention: Consecutive skin-to-skin contact is applied to newborns born by cesarean section, first by the father for 30 minutes immediately after birth, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.

Study summary

This randomized controlled study aims to evaluate the effect of consecutive skin-to-skin contact applied by the mother and father on breastfeeding parameters and parent-infant bonding in babies born by cesarean section. The study includes two groups: an intervention group receiving consecutive skin-to-skin contact by the father followed by the mother, and a control group receiving routine postnatal care. Breastfeeding success and parental bonding will be assessed using validated measurement tools during the early postnatal period and follow-up.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion criteria: * Mothers who delivered by cesarean section * Mothers and fathers willing to participate and provide written informed consent * Newborns who are stable after birth * No health conditions in mothers or fathers that would prevent participation in skin-to-skin contact Exclusion criteria: * Serious maternal or neonatal illness * Newborns requiring NICU admission * Mothers or fathers unwilling to participate * Any maternal or paternal condition preventing the implementation of skin-to-skin contact Additional note: -Eligibility is based on biological sex (female for mothers, male for fathers, newborns of any sex), not on gender identity.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zeytinburnu Avrasya Hospitol Istanbul Istanbul

More Istanbul University - Cerrahpasa trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07410754 on ClinicalTrials.gov ↗ ← All trials in Turkey